Senate Budget Draft Would Be Less Generous To US FDA Than House For FY 2023

 
• By Derrick Gingery

Senate appropriations bill would take back some of the increase the House offered the Center for Drug Evaluation and Research and other programs, setting up negotiations as next fiscal year nears.

comparing coins
The Senate offered less of an increase in FY 2023 funding for the FDA than the House of Representatives. • Source: Shutterstock

More from Legislation

More from Pink Sheet